IP Library Granted Patent US 7,553,824
Granted Patent B2
US 7,553,824 · App. 12/117,999 · Granted Jun 30, 2009

Kit for determining polysaccharide-binding activity of mononuclear cells present in peripheral blood

Assignee: Ajinomoto Co., Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,553,824
App. No.
12/117,999
Granted
Jun 30, 2009
Kind
B2
Abstract

A kit for the determination of the ability of a peripheral blood mononuclear cell to bind to a polysaccharide herein provided comprises a detection reagent comprising a fluorescence-labeled immunostimulant polysaccharide; and a reference reagent comprising a fluorescence-labeled material of a polysaccharide different from that used in the fluorescence-labeled immunostimulant polysaccharide, and/or an immunostimulant polysaccharide which is not labeled with any fluorescent material and whose polysaccharide moiety is identical to that included in the fluorescence-labeled immunostimulant polysaccharide. The use of this kit would permit the estimation of the polysaccharide-binding ability of a peripheral blood mononuclear cell in a higher precision of estimation.

Claims (20)

1. A kit for determining the activity of a peripheral blood mononuclear cell to bind to a polysaccharide, which comprises a detection reagent comprising a fluorescence-labeled immunostimulant polysaccharide; and a reference reagent,

wherein said reference reagent comprises a fluorescence-labeled material of a polysaccharide which is different from that in the fluorescence-labeled immunostimulant polysaccharide present in the detection reagent.

2. The kit of claim 1 , wherein the immunostimulant polysaceharide is a β-glucan.

3. The kit of claim 1 , wherein the immunostimulant polysaccharide is lentinan.

4. The kit of claim 1 , wherein the detection reagent and the reference reagent are liquid, respectively and contained in separate containers.

5. The kit of claim 4 , wherein said immunostimulant polysaccharide is a member selected from the group consisting of a β-glucan, an α-glucan, a hetero-glucan, and a protein-bound glucan.

6. The kit of claim 4 , wherein said immunostimulant polysaccharide is a β-glucan.

7. The kit of claim 4 , wherein said immunostimulant polysaccharide is a β-glucan selected from the group consisting of lentinan, zymosan, pachymaran, schizophyllan, pustulan, scleroglucan, and lichenan.

8. The kit of claim 4 , which further comprises a hemolysis/fixation liquid.

9. The kit of claim 8 , wherein said immunostimulant polysaccharide is a member selected from the group consisting of a β-glucan, an α-glucan, a hetero-glucan, and a protein-bound glucan.

10. The kit of claim 8 , wherein said immunostimulant polysaccharide is a β-glucan.

11. The kit of claim 8 , wherein said immunostimulant polysaccharide is a β-glucan selected from the group consisting of lentinan, zymosan, pachymaran, schizophyllan, pustulan, scieroglucan, and lichenan.

12. The kit of claim 8 , which further comprises a washing/analysis liquid.

13. The kit of claim 12 , wherein said immunostimulant polysaccharide is a member selected from the group consisting of a β-glucan, an α-glucan, a hetero-glucan, and a protein-bound glucan.

14. The kit of claim 12 wherein said immunostimulant polysaccharide is aβ-glucan.

15. The kit of claim 12 , wherein said immunostimulant polysaccharide is a β-glucan selected from the group consisting of lentinan, zymosan, pachymaran, schizophyllan, pustulan, scleroglucan, and lichenan.

16. The kit of claim 1 , wherein the reference reagent further comprises an immunostimulant polysaccharide which is not labeled with any fluorescent material and whose polysaccharide moiety is identical to that in the fluorescence-labeled immunostimulant polysaccharide in the detection reagent.

17. The kit of claim 1 , which further comprises a blood-collection tube.

18. The kit of claim 1 , wherein said immunostimulant polysaccharide is a member selected from the group consisting of a β-glucan, an α-glucan, a hetero-glucan, and a protein-bound glucan.

19. The kit of claim 1 , wherein said immunostimulant polysaccharide is a β-glucan selected from the group consisting of lentinan, zymosan, pachymaran, schizophyllan, pustulan, scieroglucan, and lichenan.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2016
From: AJINOMOTO CO., INC.
To: EA PHARMA CO., LTD.
Reel/Frame 039094/0087 →
Priority Claims (3)
JP 2004-121616 · Apr 16, 2004 · national
JP 2004-233513 · Aug 10, 2004 · national
JP 2005-036312 · Feb 14, 2005 · national
Continuity (3)
Division 1158093600 · Oct 16, 2006
Continuation PCTJP200500730600 · Apr 15, 2005
Related Publication 20080220452A1 · Sep 11, 2008